Belgium· BE-AMP-SAM663878-00
Eylea 114.3 mg/ml
A aflibercept product containing aflibercept, registered in Belgium by Bayer. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Aflibercept is registered in 11 of 19 countries.
Countries holding a registration under ATC S01LA05 (aflibercept), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Aflibercept · ATC S01LA05
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Aflibercept
- Manufacturer
- Bayer
- Country
- Belgium (BE)
- ATC code
- S01LA05
- ATC class
- Aflibercept
- Defined daily dose
- 0.018 DE, IVT
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb7748502
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aflibercept in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenEylea 114,3 mg/ml Injektionsvätska, lösningBayer AG
- CzechiaEYLEABayer AG, Leverkusen
- SpainEYLEA 114,3 MG/ML SOLUCION INYECTABLEBayer Ag
- FranceEYLEA 114,3 mg/mL, solution injectableBAYER AG (ALLEMAGNE)
- IrelandEylea 114.3 mg/ml solution for injectionBayer AG
- IcelandEyleaBayer AG*
- NetherlandsEylea 114,3 mg/ml oplossing voor injectieBayer AG
- NorwayEyleaBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Vgenfli
- Iceland · Afiveg, Afqlir
- Liechtenstein · Afiveg, Afqlir
- Norway · Afiveg, Afqlir
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/19f3d924-4fd6-4eb1-a2d2-82455647ed9c GET /v1/drugs/19f3d924-4fd6-4eb1-a2d2-82455647ed9c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled syringe",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Eylea 114.3 mg/ml",
"name_fr": "Eylea 114.3 mg/ml",
"name_nl": "Eylea 114.3 mg/ml",
"amp_code": "SAM663878-00",
"strengths": [
"114.3000",
"114.3000"
],
"pack_count": 1,
"substances": [
"Aflibercept",
"Sucrose",
"Polysorbate 20"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Aflibercept",
"authorisation_numbers": [
"EU/1/12/797/004"
]
}See everything about aflibercept.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.